Yes, the Big Bad COVID Boogie Man is still being used as a tool for the FDA to bypass clinical trials and long term studies.
Yesterday, the FDA extended emergency use authorization to a new monoclonal antibody for prevention of COVID infection in severely immunocompromised patients – like those with blood cancers and organ transplant recipients
https://www.statnews.com/2024/03/22/covid-immunocompromised-antibody-protection-invivyd/
The company producing these antibodies, Invivyd, has a statement on their website admitting to the use of human embryos in their research and development. They claim that at no time are human embryos used in the production of their new EUA antibodies, but they also tell readers not to worry about that because the human embryonic stem cells they use “meet the highest ethical standards set by leading scientific authorities are used during the earliest stages of our research. This approach is essential to the field of drug discovery and development, providing important insights that have led and will continue to lead to the creation of new medicines that positively impact global health.”
It’s for your health, see? Don’t worry about the slaughter of innocents. Nothing to see here…..move along
